Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review

BACKGROUND: Everolimus was recently approved for the treatment of neuroendocrine tumors. However, its efficacy and tolerability in hemodialysis patients with end-stage renal disease is not established. CASE PRESENTATION: We describe the case of a 47-year-old man with end-stage renal disease who rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Brizzi, M. P., La Salvia, A., Tampellini, M., Sonetto, C., Volante, M., Scagliotti, G. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861646/
https://www.ncbi.nlm.nih.gov/pubmed/29558899
http://dx.doi.org/10.1186/s12885-018-4205-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861646/
https://www.ncbi.nlm.nih.gov/pubmed/29558899
http://dx.doi.org/10.1186/s12885-018-4205-0

Ejemplares similares